Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC7A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC35G2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF416 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HCFC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL37A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC389906 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CARD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP5A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060373 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL10A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AASDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BOLA2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHX33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANXA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on